The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 30, 2011
Filed:
Nov. 02, 2009
Lisa Selsam Beavers, Franklin, IN (US);
Don Richard Finley, Greenwood, IN (US);
Terry Patrick Finn, Basingstoke, GB;
Robert Alan Gadski, Indianapolis, IN (US);
Philip Arthur Hipskind, New Palestine, IN (US);
William Joseph Hornback, Fishers, IN (US);
Cynthia Darshini Jesudason, Indianapolis, IN (US);
Richard Todd Pickard, Noblesville, IN (US);
Takako Takakuwa, Indianapolis, IN (US);
Grant Mathews Vaught, Indianapolis, IN (US);
Lisa Selsam Beavers, Franklin, IN (US);
Don Richard Finley, Greenwood, IN (US);
Terry Patrick Finn, Basingstoke, GB;
Robert Alan Gadski, Indianapolis, IN (US);
Philip Arthur Hipskind, New Palestine, IN (US);
William Joseph Hornback, Fishers, IN (US);
Cynthia Darshini Jesudason, Indianapolis, IN (US);
Richard Todd Pickard, Noblesville, IN (US);
Takako Takakuwa, Indianapolis, IN (US);
Grant Mathews Vaught, Indianapolis, IN (US);
Eli Lilly and Company, Indianapolis, IN (US);
Abstract
The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, which have histamine—H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor—related diseases